CLOVES Syndrome Clinical Trials in Boston, Massachusetts
2 recruitingBoston, Massachusetts
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation
PIK3CA MutationVascular MalformationsPIK3CA-Related Overgrowth Spectrum (PROS)+4 more
Relay Therapeutics, Inc.277 enrolled31 locationsNCT06789913
Recruiting
Lymphatic Anomalies Registry for the Assessment of Outcome Data
Lymphatic MalformationCLOVES SyndromeKlippel Trenaunay Syndrome+7 more
Boston Children's Hospital1,000 enrolled1 locationNCT02399527